4
Shared Docs
4
Same-Page
4 / 4
Mentions
EPORTS 2Q '15 FINANCIAL RESULTS, Avalanche Bio Falls After Scrapping Plans for Ph.2b Study in 2H 2015-08-13 20:35:05.499 GMT By Jeremy R. Cooke (Bloomberg) -- Avalanche Biotechnologies said it won't initiate Phase 2b trial in 2H of 2015 after further analyses of previously reported Phase 2a data of AVA
k Link to Company News:{AAVL US <Equity> CN <GO>) For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: (NH BFW<GO>} EFTA00848761 To contact the editor responsible for this story: Jeremy R. Cooke at +1-617-210-4654 or [email protected] This communicati
/09 21:51 *S&P: BRAZIL (FEDERATIVE REPUBLIC OF) TO BB+/NEGATIVE FROM BBB-/ Brazil Cut to Junk by S&P 2015-09-09 21:53:08.24 GMT By Ryan Lovdahl (Bloomberg) -- Outlook negative. Link to Company News:(1323Z BZ <Equity> CN <GO>) For Related News and Information: First Word scrolling panel: (FIRST<GO>)
Link to Company News:(1323Z BZ <Equity> CN <GO>) For Related News and Information: First Word scrolling panel: (FIRST<GO>) First Word newswire: (NH BFW<GO>) To contact the editor responsible for this story: Ryan Lovdahl at +1-212-617-6282 or rlovdahl8bloomberg.net This communication may contain c
n is available=upon request. + CLO: Market on Stronger Footing in 2015 as Questions Linger 2015-01-05 15:16:23.880 GMT By Christopher DeReza (Bloomberg) -- CLO market set to start 2015 on notably<=r> stronger ground than last year, when activity paused amid uncertainty over Volcker rule, which was
casts of $70b to $110b are still described as strong For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO> To contact the reporter on this story: Christopher DeReza in New York at +1.212.617-0863 or [email protected] <mailto:cderezal@bloomberg.
REPORTS 2Q'15 FINANCIAL RESULTS, Avalanche Bio Falls After Scrapping Plans for Ph.2b Study in 2H 2015-08-13 20:35:05.499 GMT By Jeremy R. Cooke (Bloomberg) -- Avalanche Biotechnologies said it won't initiate Phase 2b trial in 2H of 2015 after further analyses of previously reported Phase 2a data of AVA
k Link to Company News:(AAVL US <Equity> CN <GO>) For Related News and Information: First Word scrolling panel: (FIRST<GO>) First Word newswire: {NH BFW<GO>} To contact the editor responsible for this story: Jeremy R. Cooke at or CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0060257 C
Entities connected to both Bloomberg L.P. and NH BFW

Jeffrey Epstein
PERSON
Richard Kahn
PERSON
Paul Ryan
PERSON
Daniel Sabba
PERSON
Ariane de Rothschild
PERSON
Ariane Dwyer
PERSONAVA-101
ORGANIZATIONAvalanche Bio Falls
PERSONJeremy R. Cooke
PERSONAvalanche Biotechnologies, Inc.
ORGANIZATIONAVA-101 Program
ORGANIZATIONpost-mkt
ORGANIZATIONControversial Data
ORGANIZATION